NUKKW vs TECH · rev $5.9M vs P/E 65, rev $1.22B
Nukkleus Inc (NUKKW) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Nukkleus Inc (NUKKW) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NUKKW revenue for 2024-09-30 was $5.9M. Net income was -$8.5M. Revenue was down 72.2% from 2023-09-30 to 2024-09-30. NUKKW currently screens at market cap $1.21B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NUKKW currently screens at market cap $1.21B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NUKKW and TECH stock pages for the full models.
Not investment advice.